NFE2L2 and glioblastoma: In clinical samples from patients with glioblastoma, elevated mitochondrial NIX expression levels were identified as a marker of GSCs, and hypoxia-induced elevations in NIX levels were linked to increased ROS-driven NRF2 expression, further contributing to CSC stemness through HIF/mTOR activation63.